Stockholders re-elect three Class I directors, ratify KPMG, and approve executive compensation on advisory basis

Vera Therapeutics, Inc.

Elected three Class I directors (Fordyce, Seidenberg, Hall) each with >49M votes for, ~5.4M withheld, and 1.8M broker non-votes.
Ratified KPMG LLP as auditor for FY2025 with 56.6M votes for and only 3,556 against.
Advisory 'Say-on-Pay' approved with 52.98M votes for (96.6% of votes cast).
Stockholders recommended annual advisory vote on executive compensation (54.8M votes for 'One Year'); company to hold annual votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.